Target Gene/Pathway(薬物標的遺伝子/パスウェイリスト)💬 Info on mouse-over

26 / 286 pathways

No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related
KEGG GENES KEGG DRUG DrugBank 指定難病告示番号
1 AGE-RAGE signaling pathway in diabetic complications 💬
1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
2 AGE-RAGE signaling pathway in diabetic complications 💬
2件: VEGFA, VEGFB 💬 D09574 💬 Aflibercept 2件: 90, 166 💬
3 Bladder cancer 💬
1件: VEGFA 💬 D09574 💬 Aflibercept 2件: 90, 166 💬
4 Bladder cancer 💬
1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
5 Calcium signaling pathway 💬
1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
6 Calcium signaling pathway 💬
2件: VEGFA, VEGFB 💬 D09574 💬 Aflibercept 2件: 90, 166 💬
7 Collecting duct acid secretion 💬
2件: ATP4A, ATP4B 💬 D00355 💬 Lansoprazole 7件: 63, 71, 85, 98, 166, 222, 299 💬
8 EGFR tyrosine kinase inhibitor resistance 💬
1件: VEGFA 💬 D09574 💬 Aflibercept 2件: 90, 166 💬
9 EGFR tyrosine kinase inhibitor resistance 💬
1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
10 Fluid shear stress and atherosclerosis 💬
1件: VEGFA 💬 D09574 💬 Aflibercept 2件: 90, 166 💬
11 Fluid shear stress and atherosclerosis 💬
1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
12 Focal adhesion 💬
3件: PGF, VEGFA, VEGFB 💬 D09574 💬 Aflibercept 2件: 90, 166 💬
13 Focal adhesion 💬
1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
14 Gastric acid secretion 💬
2件: ATP4A, ATP4B 💬 D00355 💬 Lansoprazole 7件: 63, 71, 85, 98, 166, 222, 299 💬
15 HIF-1 signaling pathway 💬
1件: VEGFA 💬 D09574 💬 Aflibercept 2件: 90, 166 💬
16 HIF-1 signaling pathway 💬
1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
17 Human cytomegalovirus infection 💬
1件: VEGFA 💬 D09574 💬 Aflibercept 2件: 90, 166 💬
18 Human cytomegalovirus infection 💬
1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
19 Human papillomavirus infection 💬
1件: VEGFA 💬 D09574 💬 Aflibercept 2件: 90, 166 💬
20 Human papillomavirus infection 💬
1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
21 Kaposi sarcoma-associated herpesvirus infection 💬
1件: VEGFA 💬 D09574 💬 Aflibercept 2件: 90, 166 💬
22 Kaposi sarcoma-associated herpesvirus infection 💬
1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
23 MAPK signaling pathway 💬
3件: PGF, VEGFA, VEGFB 💬 D09574 💬 Aflibercept 2件: 90, 166 💬
24 MAPK signaling pathway 💬
1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
25 Metabolic pathways 💬
2件: ATP4A, ATP4B 💬 D00355 💬 Lansoprazole 7件: 63, 71, 85, 98, 166, 222, 299 💬
26 MicroRNAs in cancer 💬
1件: VEGFA 💬 D09574 💬 Aflibercept 2件: 90, 166 💬
27 MicroRNAs in cancer 💬
1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
28 Oxidative phosphorylation 💬
2件: ATP4A, ATP4B 💬 D00355 💬 Lansoprazole 7件: 63, 71, 85, 98, 166, 222, 299 💬
29 Pancreatic cancer 💬
1件: VEGFA 💬 D09574 💬 Aflibercept 2件: 90, 166 💬
30 Pancreatic cancer 💬
1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
31 Pathways in cancer 💬
3件: PGF, VEGFA, VEGFB 💬 D09574 💬 Aflibercept 2件: 90, 166 💬
32 Pathways in cancer 💬
1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
33 PI3K-Akt signaling pathway 💬
3件: PGF, VEGFA, VEGFB 💬 D09574 💬 Aflibercept 2件: 90, 166 💬
34 PI3K-Akt signaling pathway 💬
1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
35 Proteoglycans in cancer 💬
1件: VEGFA 💬 D09574 💬 Aflibercept 2件: 90, 166 💬
36 Proteoglycans in cancer 💬
1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
37 Rap1 signaling pathway 💬
3件: PGF, VEGFA, VEGFB 💬 D09574 💬 Aflibercept 2件: 90, 166 💬
38 Rap1 signaling pathway 💬
1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
39 Ras signaling pathway 💬
3件: PGF, VEGFA, VEGFB 💬 D09574 💬 Aflibercept 2件: 90, 166 💬
40 Ras signaling pathway 💬
1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
41 Relaxin signaling pathway 💬
1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
42 Relaxin signaling pathway 💬
2件: VEGFA, VEGFB 💬 D09574 💬 Aflibercept 2件: 90, 166 💬
43 Renal cell carcinoma 💬
1件: VEGFA 💬 D09574 💬 Aflibercept 2件: 90, 166 💬
44 Renal cell carcinoma 💬
1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
45 Rheumatoid arthritis 💬
1件: VEGFA 💬 D09574 💬 Aflibercept 2件: 90, 166 💬
46 Rheumatoid arthritis 💬
1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
47 VEGF signaling pathway 💬
1件: VEGFA 💬 D09574 💬 Aflibercept 2件: 90, 166 💬
48 VEGF signaling pathway 💬
1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬